Photodynamic Therapy of Oral Cavity Tumors in Low Resource Settings: Technology Development, Feasibility and Evaluation in Patients
- 1 September 2019
- conference paper
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-2
Abstract
Oral cancer is one of the leading diseases in the Southeast Asian countries due to unhealthy habits (chewing of tobacco and related preparations like Gutka). Surgery, radiotherapy and chemotherapy are expensive, require significant infrastructure and have detrimental side effects and lead to poor quality of life. We present a light-based therapy namely Photodynamic therapy (PDT) that showed promise, specifically excellent mucosal healing, in treatment of oral cancers and other malignancies. To make PDT a low-cost modality, we custom designed a battery powered light source coupled with fiber delivery and oral applicators for irradiating the lesion field. Here we demonstrate the stability of the oral applicators in human mouth followed by a pilot study in oral cancer patients to demonstrate therapy response with our custom-built light delivery system.Keywords
This publication has 10 references indexed in Scilit:
- Development and evaluation of a low‐cost, portable, LED‐based device for PDT treatment of early‐stage oral cancer in resource‐limited settingsLasers in Surgery and Medicine, 2018
- Utility of photodynamic therapy for the management of oral potentially malignant disorders and oral cancerTranslational Research in Oral Oncology, 2016
- Low-cost photodynamic therapy devices for global health settings: Characterization of battery-powered LED performance and smartphone imaging in 3D tumor modelsScientific Reports, 2015
- In vivoevaluation of battery-operated light-emitting diode-based photodynamic therapy efficacy using tumor volume and biomarker expression as endpointsJournal of Biomedical Optics, 2015
- Photodynamic Therapy with 3-(1′-Hexyloxyethyl) Pyropheophorbide a for Cancer of the Oral CavityClinical Cancer Research, 2013
- Photodynamic therapy outcome for T1/T2 N0 oral squamous cell carcinomaLasers in Surgery and Medicine, 2011
- Temoporfin‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter studyHead & Neck, 2010
- PHOTOFRIN‐mediated photodynamic therapy for treatment of early stage (Tis‐T2N0M0) SqCCa of oral cavity and oropharynxLasers in Surgery and Medicine, 2010
- Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan®) in the management of squamous cell carcinoma of the head and neck: experience with 35 patientsEuropean Archives of Oto-Rhino-Laryngology, 2009
- Photodynamic therapy using mTHPC for malignant disease in the oral cavityInternational Journal of Cancer, 1997